Richard B. Womer

Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group

Paul A. Meyers, Cindy L. Schwartz, Mark Krailo et al. · Journal of Clinical Oncology · 2008 · 734 citations · Full text

Randomized Controlled Trial of Interval-Compressed Chemotherapy for the Treatment of Localized Ewing Sarcoma: A Report From the Children's Oncology Group

Richard B. Womer, Daniel C. West, Mark Krailo et al. · Journal of Clinical Oncology · 2012 · 731 citations · Full text

Osteosarcoma: A Randomized, Prospective Trial of the Addition of Ifosfamide and/or Muramyl Tripeptide to Cisplatin, Doxorubicin, and High-Dose Methotrexate

Paul A. Meyers, Cindy L. Schwartz, Mark Krailo et al. · Journal of Clinical Oncology · 2005 · 711 citations · Full text

EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma.

Enrique de Álava, Akira Kawai, John H. Healey et al. · Journal of Clinical Oncology · 1998 · 522 citations

Predicting cisplatin ototoxicity in children: the influence of age and the cumulative dose

Yuelin Li, Richard B. Womer, Jeffrey H. Silber · European Journal of Cancer · 2003 · 351 citations

Pharmacology, Cisplatin Ototoxicity, Pediatrics +1